Khaberni - For years, scientists have been working to develop obesity treatments that help reduce appetite without adversely affecting the body's energy or muscle mass. Despite the progress made in modern medications, there are still challenges related to side effects or metabolic imbalance.
In this context, scientific research is increasingly turning to nature, in search of biological models that can offer different and more precise solutions.
A Being with Exceptional Abilities
Among these models, snakes have caught the attention of scientists due to their exceptional ability to handle food. Some species of snakes can eat massive meals roughly equivalent to their size, and then remain for long periods without food, while maintaining normal bodily functions.
This unusual behavior has prompted researchers to try to understand the mechanisms that allow them to regulate appetite and energy so efficiently.
A recent scientific study published in the journal Nature Metabolism revealed a molecule found in snake blood that could form the basis for developing a new generation of weight loss drugs.
The study, led by researchers from Stanford, Colorado, and Baylor universities, focused on understanding how snakes deal with huge meals without losing their metabolic balance.
The study relied on analyzing the blood of types of snakes, specifically the "Burmese python", before eating and afterwards, aiming to track the chemical changes that accompany the digestion process.
When studying what happens inside a snake's body after eating, it was found that there are rapid and significant changes in metabolic processes. The energy burning rate significantly increases, and vital organs operate with higher efficiency to digest the meal. These changes are not random but are regulated by a complex network of chemical signals that travel through the blood.
Discovery of the molecule pTOS
To understand this process more precisely, researchers analyzed the blood components of snakes before and after feeding. This analysis revealed hundreds of compounds whose concentrations change after eating, but one of these compounds was particularly interesting. Known as "pTOS", it was noted that its levels rise very significantly after eating compared to fasting conditions.
When scientists tested this molecule on animals suffering from obesity, the results were remarkable. It led to a reduction in the amount of food these animals consume and contributed to weight loss, without causing a decrease in activity or loss in muscle mass.
The significance of these results lies in the fact that they address one of the most prominent problems with current obesity medications, which sometimes affect the body's energy or muscle structure.
Direct Targeting
Preliminary studies indicate that this molecule works differently from most of the existing drugs. Instead of affecting the stomach or slowing down the digestive process, it appears to directly target areas in the brain responsible for regulating the sensations of hunger and satiety. This means it may help to reduce the desire to eat from the source, the neural signals themselves.
Moreover, an important aspect of this discovery is that this compound is not entirely foreign to the human body, but exists in it in small amounts, and naturally rises after eating. This could simplify its development as a treatment in the future because it relies on a mechanism already present in the body, rather than introducing a completely foreign substance.
Conversely, most current obesity drugs affect the digestive system or hormones associated with it. While they are effective, they can cause side effects such as nausea or digestive disturbances. However, this new discovery proposes the possibility of developing a treatment that works in a more balanced way, by regulating the appetite without heavily impacting other body functions.
Still, this research path is in its early stages. The experiments have been conducted on animals only so far, and wide-scale clinical studies on humans have not yet begun. This means that the path is still long before the effectiveness and safety of this molecule for medical use can be confirmed.
Anticipated Challenges
Researchers anticipate challenges including determining appropriate dosages, understanding long-term effects, and ensuring no unexpected side effects. Success in animal results does not necessarily guarantee the same for humans, which calls for further caution and study.
Despite these reservations, this discovery reflects an important trend in scientific research, based on benefitting from natural models to understand the human body more deeply. Instead of developing medications that only suppress appetite in traditional ways, scientists are moving towards "resetting" the same hunger mechanisms, achieving a better balance between the need for nutritional intake and maintaining health.
If these results prove effective in the future, we might witness a new generation of obesity drugs that precisely regulates appetite without impacting energy or muscle mass, representing a significant shift in how one of the most prevalent health problems globally is addressed.
